Orthomyxoviridae Infections
Recent clinical, regulatory, research and industry developments relating to this disease.
Variation in the basal immune state and implications for disease.
The gut-lung axis in influenza A: the role of gut microbiota in immune balance.
Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase.
Influenza A virus is transmissible via aerosolized fomites.
A Global Perspective on H9N2 Avian Influenza Virus.
Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial with recent milestones (1 completed or reporting results).
Clinical MilestonesViewHide
- 2026-05-13ClinicalA Phase 2, Randomized, Study to Evaluate Safety and Immunogenicity of One or Two Heterologous Booster Vaccinations With an MF59-adjuvanted, Cell Culture-derived H5N6 Influenza Vaccine in Adults Primed With MF59-adjuvanted, Cell Culture-derived H5N1 Influenza Vaccine or UnprimedResults posted
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Influenza A virus3
- Influenza, Human3
- Orthomyxoviridae Infections3
- Gastrointestinal Microbiome2
- Bifidobacterium animalis1
- Fomites1
- Orthomyxoviridae1
- Particulate Matter1
Leading journals6
- Frontiers in immunology2
- eLife1
- Genome biology1
- Nature communications1
- The Journal of experimental medicine1
- Virology journal1
Leading researchers8
- Wei H2
- Asadi S1
- Barre RS1
- Bouvier NM1
- Cao G1
- Chen LL1
- Chen X1
- Chen Y1
Affiliations (unnormalised)6
- St. Jude Children's Research Hospital2
- Air Quality Research Center1
- College of Veterinary Medicine1
- Hubei Key Laboratory of Agricultural Bioinformatics1
- Icahn School of Medicine at Mount Sinai1
- Imperial College London1
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Orthomyxoviridae infections are viral diseases caused by members of the Orthomyxoviridae family. The supplied literature focuses mainly on influenza viruses, including influenza A and H9N2 avian influenza, which can cause severe respiratory illness in humans and animals and have zoonotic and pandemic potential.
These infections are caused by Orthomyxoviridae viruses, with influenza A viruses emphasized in the supplied grounding. H9N2 avian influenza viruses are described as widespread in poultry and capable of zoonotic infection, indicating animal reservoirs and cross-species transmission as relevant sources of infection.
Influenza A virus pathogenesis involves viral attachment, entry, and release from infected cells, with neuraminidase acting as a sialidase that cleaves sialic acids from host cell surfaces and nascent virions. The literature also describes overactivation of the innate immune response, leading to hypercytokinemia and immune-mediated injury, and notes that gut microbiota can modulate immune balance through the gut-lung axis.
Obesity is identified as a risk factor for increased severity and mortality in influenza A infection, with delayed and blunted antiviral responses and poorer recovery. The literature also highlights susceptibility shaped by the basal immune state, pre-existing immunity, and exposure to zoonotic avian influenza viruses such as H9N2 in poultry-associated settings.
Vaccination is described as the traditional best way to prevent influenza A infection. The supplied reviews also discuss antiviral drug classes including neuraminidase inhibitors such as oseltamivir and the cap-dependent endonuclease inhibitor baloxavir, while noting that antiviral resistance and reduced vaccine effectiveness can limit control. Additional approaches under study include targeting neuraminidase and modulating the gut microbiota, but these are presented as investigational rather than established standard care.
AI-generated summary grounded in MeSH and 5 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Virus diseases caused by the ORTHOMYXOVIRIDAE.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.